buserelin has been researched along with Flushing in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Faure, N; Fazekas, AT; Jean, C; Lemay, A; Maheux, R | 1 |
| de Voogt, HJ | 1 |
| Fraser, HM; Howie, PW; Kerr-Wilson, RH; McNeilly, AS; Sandow, J; Shaw, RW | 1 |
| Koutsilieris, M; Tolis, G | 1 |
2 trial(s) available for buserelin and Flushing
| Article | Year |
|---|---|
[Prostate cancer; hormonal treatment in a new stage?].
Topics: Aged; Buserelin; Clinical Trials as Topic; Erectile Dysfunction; Flushing; Humans; Male; Middle Aged; Palliative Care; Prostatic Neoplasms | 1986 |
Long-term follow-up of patients with advanced prostatic carcinoma treated with either buserelin (HOE 766) or orchiectomy: classification of variables associated with disease outcome.
Topics: Acid Phosphatase; Bone and Bones; Buserelin; Estradiol; Flushing; Follow-Up Studies; Humans; Male; Orchiectomy; Prostatic Neoplasms; Radionuclide Imaging; Testosterone; Ultrasonics | 1985 |
2 other study(ies) available for buserelin and Flushing
| Article | Year |
|---|---|
Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis.
Topics: Adolescent; Adult; Biopsy; Buserelin; Depression, Chemical; Endometriosis; Endometrium; Estradiol; Female; Flushing; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Ovulation; Pelvic Neoplasms; Time Factors; Uterine Hemorrhage | 1984 |
Effect of an intranasal LHRH agonist on gonadotrophins and hot flushes in post-menopausal women.
Topics: Administration, Intranasal; Adult; Buserelin; Female; Flushing; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Luteinizing Hormone; Menopause; Middle Aged | 1985 |